{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:10:41Z","timestamp":1789081841721,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\u201cPioneer\u201d and \u201cLeading Goose\u201d R&D Program of Zhejiang","award":["2023C03075"],"award-info":[{"award-number":["2023C03075"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58351-y","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T07:06:35Z","timestamp":1782025595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cumulative visceral fat burden and progression to advanced cardiovascular kidney metabolic syndrome in Chinese middle-aged and older adults"],"prefix":"10.1038","volume":"16","author":[{"given":"Zihan","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danna","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"58351_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele, C. E. et al. Cardiovascular-kidney-metabolic health: A presidential advisory from the American Heart Association. Circulation 148, 1606\u20131635. https:\/\/doi.org\/10.1161\/CIR.0000000000001184 (2023).","journal-title":"Circulation"},{"key":"58351_CR2","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1111\/dom.14829","volume":"24","author":"T Kadowaki","year":"2022","unstructured":"Kadowaki, T. et al. Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on japan. Diabetes Obes. Metab. 24, 2283\u20132296. https:\/\/doi.org\/10.1111\/dom.14829 (2022).","journal-title":"Diabetes Obes. Metab."},{"key":"58351_CR3","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/ijms20092358","volume":"20","author":"M Longo","year":"2019","unstructured":"Longo, M. et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int. J. Mol. Sci. 20, 2358. https:\/\/doi.org\/10.3390\/ijms20092358 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"58351_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01937-x","volume":"22","author":"M Marassi","year":"2023","unstructured":"Marassi, M. & Fadini, G. P. The cardio-renal-metabolic connection: A review of the evidence. Cardiovasc. Diabetol. 22, 195. https:\/\/doi.org\/10.1186\/s12933-023-01937-x (2023).","journal-title":"Cardiovasc. Diabetol."},{"issue":"21","key":"58351_CR5","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal, R., Ostrominski, J. W. & Vaduganathan, M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011\u20132020. JAMA 3311858. https:\/\/doi.org\/10.1001\/jama.2024.6892 (2024).","journal-title":"JAMA"},{"key":"58351_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jacasi.2024.12.003","volume":"5","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. Prevalence of cardiovascular-kidney-metabolic syndrome stages among middle-aged and older adults in China. JACC Asia 5, 393\u2013395. https:\/\/doi.org\/10.1016\/j.jacasi.2024.12.003 (2025).","journal-title":"JACC Asia"},{"key":"58351_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41581-025-00957-y","volume":"21","author":"EF Carney","year":"2025","unstructured":"Carney, E. F. Cardiovascular mortality increases with stage of cardiovascular-kidney-metabolic syndrome. Nat. Rev. Nephrol. 21, 283. https:\/\/doi.org\/10.1038\/s41581-025-00957-y (2025).","journal-title":"Nat. Rev. Nephrol."},{"key":"58351_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.100985","volume":"22","author":"J Li","year":"2025","unstructured":"Li, J. & Wei, X. Association of cardiovascular-kidney-metabolic syndrome with all-cause and cardiovascular mortality: A prospective cohort study. Am. J. Prev. Cardiol. 22, 100985. https:\/\/doi.org\/10.1016\/j.ajpc.2025.100985 (2025).","journal-title":"Am. J. Prev. Cardiol."},{"key":"58351_CR9","doi-asserted-by":"publisher","first-page":"110773","DOI":"10.1016\/j.diabres.2023.110773","volume":"202","author":"C Boutari","year":"2023","unstructured":"Boutari, C., DeMarsilis, A. & Mantzoros, C. S. Obesity and diabetes. Diabetes Res. Clin. Pract. 202, 110773. https:\/\/doi.org\/10.1016\/j.diabres.2023.110773 (2023).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"58351_CR10","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1161\/CIRCULATIONAHA.117.029617","volume":"137","author":"IJ Neeland","year":"2018","unstructured":"Neeland, I. J., Poirier, P. & Despr\u00e9s, J-P. Cardiovascular and metabolic heterogeneity of obesity: Clinical challenges and implications for management. Circulation 137, 1391\u20131406. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029617 (2018).","journal-title":"Circulation"},{"key":"58351_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1053\/j.ajkd.2020.08.016","volume":"77","author":"K Chintam","year":"2021","unstructured":"Chintam, K. & Chang, A. R. Strategies to treat obesity in patients with CKD. Am. J. Kidney Dis. 77, 427\u2013439. https:\/\/doi.org\/10.1053\/j.ajkd.2020.08.016 (2021).","journal-title":"Am. J. Kidney Dis."},{"key":"58351_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.semnephrol.2012.12.002","volume":"33","author":"C R\u00fcster","year":"2013","unstructured":"R\u00fcster, C. & Wolf, G. The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases. Semin Nephrol. 33, 44\u201353. https:\/\/doi.org\/10.1016\/j.semnephrol.2012.12.002 (2013).","journal-title":"Semin Nephrol."},{"key":"58351_CR13","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.metabol.2013.07.001","volume":"62","author":"AR Aroor","year":"2013","unstructured":"Aroor, A. R. et al. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism 62, 1543\u20131552. https:\/\/doi.org\/10.1016\/j.metabol.2013.07.001 (2013).","journal-title":"Metabolism"},{"key":"58351_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/TP.0000000000005183","volume":"109","author":"H Zhou","year":"2025","unstructured":"Zhou, H. et al. Obesity-associated inflammation and alloimmunity. Transplantation 109, 588\u2013596. https:\/\/doi.org\/10.1097\/TP.0000000000005183 (2025).","journal-title":"Transplantation"},{"key":"58351_CR15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1017\/S0029665111000565","volume":"70","author":"KA Harford","year":"2011","unstructured":"Harford, K. A., Reynolds, C. M., McGillicuddy, F. C. & Roche, H. M. Fats, inflammation and insulin resistance: Insights to the role of macrophage and T-cell accumulation in adipose tissue. Proc. Nutr. Soc. 70, 408\u2013417. https:\/\/doi.org\/10.1017\/S0029665111000565 (2011).","journal-title":"Proc. Nutr. Soc."},{"key":"58351_CR16","doi-asserted-by":"publisher","first-page":"12699","DOI":"10.1038\/s41598-020-69498-7","volume":"10","author":"I Sommer","year":"2020","unstructured":"Sommer, I. et al. The performance of anthropometric tools to determine obesity: A systematic review and meta-analysis. Sci. Rep. 10, 12699. https:\/\/doi.org\/10.1038\/s41598-020-69498-7 (2020).","journal-title":"Sci. Rep."},{"key":"58351_CR17","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s13679-024-00580-1","volume":"13","author":"K Sweatt","year":"2024","unstructured":"Sweatt, K., Garvey, W. T. & Martins, C. Strengths and limitations of BMI in the diagnosis of obesity: What is the path forward?. Curr. Obes. Rep. 13, 584\u2013595. https:\/\/doi.org\/10.1007\/s13679-024-00580-1 (2024).","journal-title":"Curr. Obes. Rep."},{"key":"58351_CR18","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.clnu.2019.07.012","volume":"39","author":"OY Bello-Chavolla","year":"2020","unstructured":"Bello-Chavolla, O. Y. et al. Metabolic score for visceral fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health. Clin. Nutr. 39, 1613\u20131621. https:\/\/doi.org\/10.1016\/j.clnu.2019.07.012 (2020).","journal-title":"Clin. Nutr."},{"key":"58351_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110842","author":"Y Zhu","year":"2023","unstructured":"Zhu, Y. et al. Associations between metabolic score for visceral fat and the risk of cardiovascular disease and all-cause mortality among populations with different glucose tolerance statuses. Diabetes research and clinical practice https:\/\/doi.org\/10.1016\/j.diabres.2023.110842 (2023).","journal-title":"Diabetes research and clinical practice"},{"key":"58351_CR20","doi-asserted-by":"publisher","first-page":"e13702","DOI":"10.1002\/jcsm.13702","volume":"16","author":"Q Liu","year":"2025","unstructured":"Liu, Q. et al. Association of cumulative exposure to metabolic score for visceral fat with the risk of cardiovascular disease and all-cause mortality: A prospective cohort study. J. Cachexia Sarcopenia Muscle. 16, e13702. https:\/\/doi.org\/10.1002\/jcsm.13702 (2025).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"58351_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino","year":"2008","unstructured":"D\u2019Agostino, R. B. et al. General cardiovascular risk profile for use in primary care: The framingham heart study. Circulation 117, 743\u2013753. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.699579 (2008).","journal-title":"Circulation"},{"key":"58351_CR22","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1681\/ASN.2006040368","volume":"17","author":"Y-C Ma","year":"2006","unstructured":"Ma, Y.-C. et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J. Am. Soc. Nephrol. 17, 2937\u20132944. https:\/\/doi.org\/10.1681\/ASN.2006040368 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"58351_CR23","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.2147\/DMSO.S421623","volume":"16","author":"C Torun","year":"2023","unstructured":"Torun, C. et al. Is metabolic score for visceral fat (METS-VF) a better index than other adiposity indices for the prediction of visceral adiposity. Diabetes Metab. Syndr. Obes. 16, 2605\u20132615. https:\/\/doi.org\/10.2147\/DMSO.S421623 (2023).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"58351_CR24","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.5114\/aoms\/193709","volume":"20","author":"A Tan","year":"2024","unstructured":"Tan, A., Yang, S., Pan, Y. & Lin, Q. Metabolism score for visceral fat (METS-VF): An innovative and powerful predictor of stroke. Arch. Med. Sci. 20, 1710\u20131714. https:\/\/doi.org\/10.5114\/aoms\/193709 (2024).","journal-title":"Arch. Med. Sci."},{"key":"58351_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12944-025-02654-y","volume":"24","author":"D Zhang","year":"2025","unstructured":"Zhang, D. et al. Linking metabolic score for visceral fat to heart failure: Insights from national health and nutrition examination survey 2003\u20132018. Lipids Health Dis. 24, 235. https:\/\/doi.org\/10.1186\/s12944-025-02654-y (2025).","journal-title":"Lipids Health Dis."},{"key":"58351_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s42506-025-00188-w","volume":"100","author":"MY Tawfik","year":"2025","unstructured":"Tawfik, M. Y., Mohamed, S. F. & Elotla, S. F. Association of novel visceral obesity indices with 10-year risk of major cardiovascular events in patients with type 2 diabetes mellitus. J. Egypt. Public. Health Assoc. 100, 12. https:\/\/doi.org\/10.1186\/s42506-025-00188-w (2025).","journal-title":"J. Egypt. Public. Health Assoc."},{"key":"58351_CR27","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.numecd.2023.12.024","volume":"34","author":"Q He","year":"2024","unstructured":"He, Q. et al. Visceral adiposity associated with incidence and development trajectory of cardiometabolic diseases: A prospective cohort study. Nutr. Metab. Cardiovasc. Dis. 34, 1235\u20131244. https:\/\/doi.org\/10.1016\/j.numecd.2023.12.024 (2024).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"58351_CR28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/jes.2014.58","volume":"25","author":"F de Vocht","year":"2015","unstructured":"de Vocht, F., Burstyn, I. & Sanguanchaiyakrit, N. Rethinking cumulative exposure in epidemiology, again. J. Expo Sci. Environ. Epidemiol. 25, 467\u2013473. https:\/\/doi.org\/10.1038\/jes.2014.58 (2015).","journal-title":"J. Expo Sci. Environ. Epidemiol."},{"key":"58351_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12933-024-02511-9","volume":"23","author":"C Duan","year":"2024","unstructured":"Duan, C. et al. Associations of baseline and changes in the triglyceride glucose-weight adjusted waist index and cardiovascular disease risk: Evidence from middle-aged and older individuals. Cardiovasc. Diabetol. 23, 415. https:\/\/doi.org\/10.1186\/s12933-024-02511-9 (2024).","journal-title":"Cardiovasc. Diabetol."},{"key":"58351_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12933-024-02144-y","volume":"23","author":"Q Min","year":"2024","unstructured":"Min, Q. et al. Association between atherogenic index of plasma control level and incident cardiovascular disease in middle-aged and elderly Chinese individuals with abnormal glucose metabolism. Cardiovasc. Diabetol. 23, 54. https:\/\/doi.org\/10.1186\/s12933-024-02144-y (2024).","journal-title":"Cardiovasc. Diabetol."},{"key":"58351_CR31","doi-asserted-by":"publisher","first-page":"104610","DOI":"10.1016\/j.numecd.2026.104610","volume":"36","author":"L Zhao","year":"2026","unstructured":"Zhao, L. & Gao, Q. Association between cumulative exposure to metabolic score for visceral fat and the risk of stroke in a population with cardiovascular-kidney-metabolic syndrome stages 0\u20133: A nationwide prospective cohort study. Nutr. Metabolism Cardiovasc. Dis. 36, 104610. https:\/\/doi.org\/10.1016\/j.numecd.2026.104610 (2026).","journal-title":"Nutr. Metabolism Cardiovasc. Dis."},{"key":"58351_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12872-026-05511-7","volume":"26","author":"H Zhang","year":"2026","unstructured":"Zhang, H. et al. Metabolic score for visceral fat profiles and incident cardiovascular disease in adults with CKM syndrome stages 0\u20133: A CHARLS longitudinal study. BMC Cardiovasc. Disord. 26, 142. https:\/\/doi.org\/10.1186\/s12872-026-05511-7 (2026).","journal-title":"BMC Cardiovasc. Disord"},{"key":"58351_CR33","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJMra1011035","volume":"371","author":"GI Shulman","year":"2014","unstructured":"Shulman, G. I. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl. J. Med. 371, 1131\u20131141. https:\/\/doi.org\/10.1056\/NEJMra1011035 (2014).","journal-title":"N Engl. J. Med."},{"key":"58351_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/978-3-031-63657-8_14","volume":"1460","author":"D Yaz\u0131c\u0131","year":"2024","unstructured":"Yaz\u0131c\u0131, D., Demir, S. \u00c7. & Sezer, H. Insulin resistance, obesity, and lipotoxicity. Adv. Exp. Med. Biol. 1460, 391\u2013430. https:\/\/doi.org\/10.1007\/978-3-031-63657-8_14 (2024).","journal-title":"Adv. Exp. Med. Biol."},{"key":"58351_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi, N., Parker, J. L., Lugus, J. J. & Walsh, K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11, 85\u201397. https:\/\/doi.org\/10.1038\/nri2921 (2011).","journal-title":"Nat Rev Immunol"},{"key":"58351_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel, A. R. & Olefsky, J. M. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest 127, 1\u20134. https:\/\/doi.org\/10.1172\/JCI92035 (2017).","journal-title":"J Clin Invest"},{"key":"58351_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/biom15020163","volume":"15","author":"VA Ionescu","year":"2025","unstructured":"Ionescu, V. A., Gheorghe, G., Bacalbasa, N. & Diaconu, C. C. Metabolic dysfunction-associated steatotic liver disease: Pathogenetic links to cardiovascular risk. Biomolecules 15, 163. https:\/\/doi.org\/10.3390\/biom15020163 (2025).","journal-title":"Biomolecules"},{"key":"58351_CR38","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/FJC.0000000000000469","volume":"69","author":"F Schinzari","year":"2017","unstructured":"Schinzari, F., Tesauro, M. & Cardillo, C. Endothelial and perivascular adipose tissue abnormalities in obesity-related vascular dysfunction: Novel targets for treatment. J Cardiovasc Pharmacol 69, 360\u2013368. https:\/\/doi.org\/10.1097\/FJC.0000000000000469 (2017).","journal-title":"J Cardiovasc Pharmacol"},{"key":"58351_CR39","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nature05487","volume":"444","author":"LF Van Gaal","year":"2006","unstructured":"Van Gaal, L. F., Mertens, I. L. & De Block, C. E. Mechanisms linking obesity with cardiovascular disease. Nature 444, 875\u2013880. https:\/\/doi.org\/10.1038\/nature05487 (2006).","journal-title":"Nature"},{"key":"58351_CR40","doi-asserted-by":"publisher","first-page":"sfad282","DOI":"10.1093\/ckj\/sfad282","volume":"17","author":"A Parvanova","year":"2024","unstructured":"Parvanova, A., Reseghetti, E., Abbate, M. & Ruggenenti, P. Mechanisms and treatment of obesity-related hypertension-part 1: Mechanisms. Clin. Kidney J. 17, sfad282. https:\/\/doi.org\/10.1093\/ckj\/sfad282 (2024).","journal-title":"Clin. Kidney J."},{"key":"58351_CR41","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"JE Hall","year":"2015","unstructured":"Hall, J. E. et al. Obesity-induced hypertension: Interaction of neurohumoral and renal mechanisms. Circ Res 116, 991\u20131006. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.305697 (2015).","journal-title":"Circ Res"},{"key":"58351_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2337\/db12-0905","volume":"62","author":"SB Bender","year":"2013","unstructured":"Bender, S. B., McGraw, A. P., Jaffe, I. Z. & Sowers, J. R. Mineralocorticoid Receptor\u2013Mediated Vascular Insulin Resistance. Diabetes 62, 313\u2013319. https:\/\/doi.org\/10.2337\/db12-0905 (2013).","journal-title":"Diabetes"},{"key":"58351_CR43","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1016\/j.jacc.2025.08.086","volume":"86","author":"M Packer","year":"2025","unstructured":"Packer, M. et al. Chronic kidney disease in patients with heart failure with a preserved ejection fraction: The underlying role of visceral adiposity. J. Am. Coll. Cardiol. 86, 1900\u20131916. https:\/\/doi.org\/10.1016\/j.jacc.2025.08.086 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"58351_CR44","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.kint.2016.10.019","volume":"91","author":"CP Kovesdy","year":"2017","unstructured":"Kovesdy, C. P. et al. Obesity and kidney disease: Hidden consequences of the epidemic. Kidney Int. 91, 260\u2013262. https:\/\/doi.org\/10.1016\/j.kint.2016.10.019 (2017).","journal-title":"Kidney Int."},{"key":"58351_CR45","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1038\/s41598-025-86723-3","volume":"15","author":"X Zhou","year":"2025","unstructured":"Zhou, X. et al. Investigating the role of the metabolic score for visceral fat in assessing the prevalence of chronic kidney disease from the NHANES 1999\u20132018. Sci. Rep. 15, 2397. https:\/\/doi.org\/10.1038\/s41598-025-86723-3 (2025).","journal-title":"Sci. Rep."},{"key":"58351_CR46","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/life14111399","volume":"14","author":"J-C Huang","year":"2024","unstructured":"Huang, J-C. et al. Exploring the relationship between visceral fat and coronary artery calcification risk using metabolic score for visceral fat (METS-VF). Life (Basel). 14, 1399. https:\/\/doi.org\/10.3390\/life14111399 (2024).","journal-title":"Life (Basel)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58351-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58351-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58351-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:39:25Z","timestamp":1789079965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58351-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58351"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58351-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CHARLS study was performed in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Peking University. All participants provided written informed consent before participating in the CHARLS study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28380"}}